| zolpidem ER / Generic mfg. |
NCT00630175: Evaluation of the Hypnotic Properties of Zolpidem-MR 12.5 mg and Zolpidem 10 mg Marketed Product Compared to Placebo in Patients With Primary Insomnia |
|
|
| Completed | 3 | 113 | US, Canada, RoW | zolpidem-MR (modified release), zolpidem (SL800750), placebo | Sanofi | Sleep Initiation and Maintenance Disorders | 02/04 | 02/04 | | |
NCT00425243: Efficacy and Safety of Zolpidem-MR Administered Over a Long Term Period as Needed for Insomnia (ZOLONG) |
|
|
| Completed | 3 | 1025 | US | zolpidem-MR (SL800750) | Sanofi | Sleep Initiation and Maintenance Disorders | 01/06 | 01/06 | | |
NCT00999219: A Study of FK199B to Compare Efficacy With Zolpidem by Polysomnography in Patients With Insomnia |
|
|
| Completed | 3 | 55 | Japan | FK199B, Zolpidem MR Tablet, Zolpidem, Myslee | Astellas Pharma Inc | Sleep Initiation and Maintenance Disorders | 07/07 | 07/07 | | |
NCT00283946: A Double-blind, Group-comparison Study Using Zolpidem (Myslee) as a Comparative Drug in Patients With Insomnia |
|
|
| Completed | 3 | 876 | Japan | Zolpidem MR, Zolpidem, Myslee | Astellas Pharma Inc | Sleep Initiation and Maintenance Disorders, Sleep Disorders | 11/07 | 11/07 | | |
NCT00374777: A Double-blind, Group-comparison P-III Study With Zolpidem MR Using Placebo and Nitrazepam in Insomnia Patients |
|
|
| Completed | 3 | 450 | Japan | zolpidem MR, FK199B, nitrazepam, placebo | Astellas Pharma Inc | Sleep Initiation and Maintenance Disorders | 05/08 | 06/08 | | |
| Completed | 3 | 1006 | Europe, Canada, US | Lemborexant, E2006, Lemborexant-matched placebo, Zolpidem tartrate, Ambien CR, Zolpidem-matched placebo | Eisai Inc. | Insomnia | 01/18 | 01/18 | | |
NCT01685073: The Role of Sleep in the Treatment of Cannabis Use Disorders |
|
|
| Completed | 2/3 | 127 | US | Zolpidem extended-release, Ambien CR, MET/CBT | Johns Hopkins University, National Institute on Drug Abuse (NIDA) | Drug Addiction | 07/18 | 07/18 | | |
